Search research articles
Contact Us
Filters
Showing results (221-230 of 232) with videos related to
Page
of 24
Sort By:
British Heart Journal
|
January 1, 1972
Natural history of acute coronary heart attacks. A community study
A Armstrong, B Duncan, M F Oliver, et al.
JAMA
|
August 14, 2001
Atorvastatin for acute coronary syndromes
G G Schwartz, A G Olsson, M D Ezekowitz, et al.
Cor Et Vasa
|
January 1, 1986
Prediction and prevention of sudden cardiac death in myocardial ischaemia. Round table discussion by mail
A A Adgey, K H Günther, D Kalusche, et al.
British Medical Journal
|
April 24, 1976
Prognosis of new and worsening angina pectoris
B Duncan, M Fulton, S L Morrison, et al.
Lancet (London, England)
|
April 22, 1972
Natural history of unstable angina
M Fulton, W Lutz, K W Donald, et al.
European Heart Journal
|
January 1, 1986
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion
M Verstraete, B G Brown, J H Chesebro, et al.
JAMA
|
April 13, 2001
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
G G Schwartz, A G Olsson, M D Ezekowitz, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1978
The Edinburgh-Stockholm study of coronary heart disease risk factors: a summary
R L Logan, R A Riemersma, M F Oliver, et al.
The American Journal of Cardiology
|
March 26, 1998
Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction
G G Schwartz, M F Oliver, M D Ezekowitz, et al.
Lancet (London, England)
|
May 6, 1978
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study
R L Logan, R A Riemersma, M Thomson, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 232) with videos related to
Sort By:
Page
of 24
British Heart Journal
|
January 1, 1972
Natural history of acute coronary heart attacks. A community study
A Armstrong, B Duncan, M F Oliver, et al.
JAMA
|
August 14, 2001
Atorvastatin for acute coronary syndromes
G G Schwartz, A G Olsson, M D Ezekowitz, et al.
Cor Et Vasa
|
January 1, 1986
Prediction and prevention of sudden cardiac death in myocardial ischaemia. Round table discussion by mail
A A Adgey, K H Günther, D Kalusche, et al.
British Medical Journal
|
April 24, 1976
Prognosis of new and worsening angina pectoris
B Duncan, M Fulton, S L Morrison, et al.
Lancet (London, England)
|
April 22, 1972
Natural history of unstable angina
M Fulton, W Lutz, K W Donald, et al.
European Heart Journal
|
January 1, 1986
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion
M Verstraete, B G Brown, J H Chesebro, et al.
JAMA
|
April 13, 2001
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
G G Schwartz, A G Olsson, M D Ezekowitz, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1978
The Edinburgh-Stockholm study of coronary heart disease risk factors: a summary
R L Logan, R A Riemersma, M F Oliver, et al.
The American Journal of Cardiology
|
March 26, 1998
Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction
G G Schwartz, M F Oliver, M D Ezekowitz, et al.
Lancet (London, England)
|
May 6, 1978
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study
R L Logan, R A Riemersma, M Thomson, et al.
Page
of 24